6-[2-methyl-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)benzoyl]-3-oxa-6-azabicyclo[3.1.1]heptane
Structure Info
- Chemspace ID
- CSSB02533261083 (In-Stock Building Blocks)
- IUPAC Name
- 6-[2-methyl-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)benzoyl]-3-oxa-6-azabicyclo[3.1.1]heptane
- Mol formula
- C19H26BNO4
- Mol weight
- 343 Da
- Catalog Number(s)
- BBLS02533261083, BBV-331938817, EN300-55408775, bbls02533261083
- Copy structure to query editor
- SMILES
- INCHI
- INCHI key
- MOL
Properties
- LogP
- 3.18
- Heavy atoms count
- 25
- Rotatable bond count
- 2
- Number of rings
- 4
- Carbon bond saturation, Fsp3
- 0.631
- Polar surface area (Å)
- 48
- Hydrogen bond acceptors count
- 4
- Hydrogen bond donors count
- 0
![Chemical structure of 6-[2-methyl-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)benzoyl]-3-oxa-6-azabicyclo[3.1.1]heptane (C19H26BNO4) - CSSB02533261083](/st/structure/200/622a29f6a3d4a6cc599cb7997aa905c5/CC1%253DCC%253DC%2528C%253DC1C%2528%253DO%2529N1C2CC1COC2%2529B1OC%2528C%2529%2528C%2529C%2528C%2529%2528C%2529O1.png "C19H26BNO4")
- Zoom the structure
- CSSB02533261083
Items Overall 8 items from 1 supplier
| Supplier | Lead time | Ships from | Purity | Pack | Price, $ | Qty |
|---|---|---|---|---|---|---|
| Enamine Ltd. | 15 days | Ukraine To: | 95 | 50 mg | 360.00 | |
| Enamine Ltd. | 15 days | Ukraine To: | 95 | 100 mg | 376.00 | |
| Enamine Ltd. | 15 days | Ukraine To: | 95 | 250 mg | 393.00 | |
| Enamine Ltd. | 15 days | Ukraine To: | 95 | 500 mg | 410.00 | |
| Enamine Ltd. | 15 days | Ukraine To: | 95 | 1 g | 427.00 | |
| Enamine Ltd. | 15 days | Ukraine To: | 95 | 2.5 g | 838.00 | |
| Enamine Ltd. | 15 days | Ukraine To: | 95 | 5 g | 1,240.00 | |
| Enamine Ltd. | 15 days | Ukraine To: | 95 | 10 g | 1,839.00 |
For a custom pack size or bulk
please drop us a line:Enquire
please drop us a line:Enquire
Similarity Analogs
![Chemical structure of 7-[2-methyl-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)benzoyl]-7-azabicyclo[2.2.1]heptane - CSSB02533516034](/st/structure/200/c67bf355d425bfa553300693a0ee84a9/CC1%253DCC%253DC%2528C%253DC1C%2528%253DO%2529N1C2CCC1CC2%2529B1OC%2528C%2529%2528C%2529C%2528C%2529%2528C%2529O1.png)
![Chemical structure of 6-[2-methyl-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)benzoyl]-6-azabicyclo[3.1.1]heptane - CSSB02533260618](/st/structure/200/edc9b1dc9e58c72fe39fd02ce135d5f8/CC1%253DCC%253DC%2528C%253DC1C%2528%253DO%2529N1C2CC1CCC2%2529B1OC%2528C%2529%2528C%2529C%2528C%2529%2528C%2529O1.png)
![Chemical structure of 6-[4-methyl-3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)benzoyl]-3-oxa-6-azabicyclo[3.1.1]heptane - CSSB00348447415](/st/structure/200/c08a5a6aafdef6055e416cdc1a1219b1/CC1%253DCC%253DC%2528C%253DC1B1OC%2528C%2529%2528C%2529C%2528C%2529%2528C%2529O1%2529C%2528%253DO%2529N1C2CC1COC2.png)
![Chemical structure of 6-[4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)benzoyl]-3-oxa-6-azabicyclo[3.1.1]heptane - CSSB02526923855](/st/structure/200/659247f2193641ca0eeba1f395ae6595/CC1%2528C%2529OB%2528OC1%2528C%2529C%2529C1%253DCC%253DC%2528C%253DC1%2529C%2528%253DO%2529N1C2CC1COC2.png)
